• Explore /
  • Poster
  • / Impact of somatic <em>SPOP (</em>Speckle-Type POZ protein) mutation (mtSPOP) on response to systemic therapy and survival outcome in men with de novo metastatic castration-sensitive prostate cancer (d-mCSPC).

Impact of somatic SPOP (Speckle-Type POZ protein) mutation (mtSPOP) on response to systemic therapy and survival outcome in men with de novo metastatic castration-sensitive prostate cancer (d-mCSPC).

Abstract Poster

Authors

null

Umang Swami

Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

Umang Swami , Pedro Isaacsson Velho , Roberto Nussenzveig , Victor Sacristan Santos , Stephanie Erickson , Divya Dharmaraj , Ajjai Shivaram Alva , Ulka N. Vaishampayan , John Esther , Andrew W Hahn , Benjamin Louis Maughan , Emmanuel S. Antonarakis , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 329)

Abstract #

329

Poster Bd #

M13

Abstract Disclosures

Similar Posters

First Author: Sachdev P. Thomas

First Author: Joshua Parrish

First Author: Charles J. Ryan

First Author: Zachery R Reichert